These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 25876786

  • 1. [Successful treatment with rituximab and romiplostim for thrombocytopenia associated with Waldenström's macroglobulinemia initially presenting as Evans syndrome].
    Nozaki Y, Koshiishi M, Sueki Y, Kawashima I, Yamamoto T, Nakajima K, Mitsumori T, Kirito K.
    Rinsho Ketsueki; 2015 Mar; 56(3):317-22. PubMed ID: 25876786
    [Abstract] [Full Text] [Related]

  • 2. The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab.
    Gonzalez-Nieto JA, Martin-Suarez I, Quattrino S, Ortiz-Lopez E, Muñoz-Beamud FR, Colchero-Fernández J, Alcoucer-Diaz MR.
    Lupus; 2011 Oct; 20(12):1321-3. PubMed ID: 21719526
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab.
    Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Velázquez-Sánchez-de-Cima S, Zamora-Ortiz G.
    Hematology; 2013 May; 18(3):175-7. PubMed ID: 23321502
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of severe newly diagnosed immune thrombocytopenia involving an alveolar hemorrhage with combination therapy consisting of romiplostim, rituximab and vincristine.
    Okazuka K, Masuko M, Matsuo Y, Miyakoshi S, Tanaka T, Kozakai T, Kobayashi H, Fuse K, Shibasaki Y, Moriyama M, Takizawa J, Fuse I, Toba K, Furukawa T.
    Intern Med; 2013 May; 52(11):1239-42. PubMed ID: 23728563
    [Abstract] [Full Text] [Related]

  • 5. Improvement of the thermal amplitude after rituximab treatment for cold agglutinin disease with Waldenström's macroglobulinemia.
    Hattori N, Ishii N, Ariizumi H, Adachi D, Matsuda I, Nakamaki T, Tomoyasu S.
    Ann Hematol; 2010 Jan; 89(1):103-4. PubMed ID: 19513714
    [No Abstract] [Full Text] [Related]

  • 6. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.
    Mitsuhashi K, Ishiyama M, Imai Y, Shiseki M, Mori N, Teramura M, Seshimo A, Motoji T.
    Br J Haematol; 2012 Sep; 158(6):798-800. PubMed ID: 22758388
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Progression of bone marrow fibrosis with reticulin and collagen hyperplasia during treatment with the thrombopoietin receptor agonist romiplostim in a patient with immune thrombocytopenia].
    Kirito K, Komatsu N.
    Rinsho Ketsueki; 2013 Mar; 54(3):295-9. PubMed ID: 23676646
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus.
    Alkaabi JK, Alkindi S, Riyami NA, Zia F, Balla LM, Balla SM.
    Lupus; 2012 Dec; 21(14):1571-4. PubMed ID: 23161577
    [Abstract] [Full Text] [Related]

  • 10. Romiplostim for the management of perioperative thrombocytopenia.
    Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ.
    Br J Haematol; 2018 Jul; 182(1):106-113. PubMed ID: 29767837
    [Abstract] [Full Text] [Related]

  • 11. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
    Newland A, Godeau B, Priego V, Viallard JF, López Fernández MF, Orejudos A, Eisen M.
    Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
    [Abstract] [Full Text] [Related]

  • 12. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H, Giagounidis A, El-Rashaid K, Al-Ali M, Hakim AA.
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [Abstract] [Full Text] [Related]

  • 13. IgG-associated immune thrombocytopenia in Waldenström macroglobulinemia.
    Nakazaki K, Hangaishi A, Nakamura F, Hosoi M, Imai Y, Takahashi T, Nannya Y, Kurokawa M.
    Int J Hematol; 2010 Sep; 92(2):360-3. PubMed ID: 20658219
    [Abstract] [Full Text] [Related]

  • 14. Evans syndrome after unrelated bone marrow transplantation for refractory cytopenia of childhood.
    Ueki H, Igarashi S, Kimura S, Tsuchimochi T, Furudate K, Sakurai A, Noguchi Y, Sunami S.
    Pediatr Transplant; 2014 Nov; 18(7):E246-51. PubMed ID: 25074497
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia.
    Miao J, Leblebjian H, Scullion B, Parnes A.
    Am J Hematol; 2018 Aug; 93(4):E86-E88. PubMed ID: 29274130
    [No Abstract] [Full Text] [Related]

  • 17. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
    Kuter DJ, Mathias SD, Rummel M, Mandanas R, Giagounidis AA, Wang X, Deuson RR.
    Am J Hematol; 2012 May; 87(5):558-61. PubMed ID: 22460421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Romiplostim treatment allows for platelet transfusion-free liver transplantation in pediatric thrombocytopenic patient with primary sclerosing cholangitis.
    Minowa K, Arai K, Kasahara M, Sakamoto S, Shimizu H, Nakano N, Ito R, Obayashi N, Nakazawa A, Ishiguro A.
    Pediatr Transplant; 2014 Sep; 18(6):E212-5. PubMed ID: 25041553
    [Abstract] [Full Text] [Related]

  • 20. Romiplostim resistance in secondary failure of platelet recovery.
    DeRemer DL, Katsanevas K, Bradley A, Awan FT.
    J Oncol Pharm Pract; 2013 Dec; 19(4):369-72. PubMed ID: 23292974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.